Skip to content
Catalyst

knowcompoundssodium(1+)

Specimen compound element, as a monatomic cation

Sodium

A monoatomic monocation obtained from sodium.”

fig. 1Sodium · findings by direction and evidence strength
Formula
Na+
Molar mass
22.99 g/mol
InChIKey
FKNQFGJONOIPTF-UHFFFAOYSA-N

↑ raised 1 finding in 1 endpoint · ↓ lowered 3 in 3 · – no difference found 5 in 4

01 · the evidence, ordered

What the evidence says

Strong
0
Moderate
2
Limited
1
Very limited
6
Insufficient
0

How to read these marks

Fig. 2 Sodium CHEBI:29101 8 endpoints 9 findings
×1.60
Labels
CompoundInspector

Sodium

Most findings

  • All-cause mortality×2
  • Body mass×1
  • Expanded Disability Status Scale (EDSS)×1
  • Peak postprandial blood glucose×1
Show the remaining 4Show the first 4
  • Core body temperature×1
  • Rating of perceived exertion×1
  • Serum creatinine concentration×1
  • Serum sodium concentration×1

1,230 reference statements, not drawn · 36 compounds on the outer ring, not drawn

Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

  1. All-cause mortality
  2. Peak postprandial blood glucose
  3. Expanded Disability Status Scale (EDSS)
  4. Body mass
  5. Core body temperature
  6. Rating of perceived exertion
  7. Serum creatinine concentration
  8. Serum sodium concentration
fig. 3 · 8 endpoints · 9 findingsno endpoint contested

02 · findings

What sodium moved, and by how much

  • RR risk ratio · MD mean difference. Brackets: the interval as reported.
  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed
  • Industry funding: named on its row.
Direction
Strength, at least

9 shown

  1. All-cause mortalityMoved: no difference foundEffect, as reportedRR1.02[0.93 to 1.12]Evidence: Moderatereplicated ×1Paper: PMID 303405412018
    Who
    Adults in 8 prospective cohort studies reporting total mortality, sodium intake assessed by 24 h urine collection or food frequency questionnaire; per 100 mmol/day increment in sodium intake
    Dose studied
    100 mmol/day increment in sodium intake (observational gradient)

    However, the results did not reveal any significant association of 100 mmol increments per day in sodium intake with the total mortality risk (RR: 1.02; 95% CI: 0.93–1.12; P = 0.720; Fig. 2b).”

    Quoted verbatim from Association of sodium intake and major cardiovascular outcomes: a dose-response meta-analysis of prospective cohort studies.meta-analysisPermalink
  2. Peak postprandial blood glucoseMoved: lowersEffect, as reportedMD−0.481[−0.88 to −0.083]Evidence: ModeratePaper: PMID 413134322026An author is affiliated with a producer
    Who
    Eleven adults without diabetes, at least 12 months after Roux-en-Y gastric bypass; mixed meal tolerance test (orange juice and yoghurt) with versus without added NaCl
    Dose studied
    2 g additional NaCl (about 785 mg sodium) dissolved in 170 mL orange juice, single mixed meal tolerance test, versus the same meal without added NaCl

    NaCl supplementation resulted in 6% lower peak plasma glucose (mean difference − 0.481 mmol/L, 95% CI: -0.880 to -0.083 mmol/L, p = 0.022).”

    Quoted verbatim from The Effect of Increased Sodium Intake with a Carbohydrate-Rich Meal on Glucose Homeostasis in People without Diabetes after Roux-en-Y Gastric Bypass: a Proof-of-Concept, Randomized, Open-Label, Crossover Study.crossoverPermalink
  3. Expanded Disability Status Scale (EDSS)Moved: no difference foundEvidence: LimitedPaper: PMID 285564982017
    Who
    465 patients with a clinically isolated syndrome in the BENEFIT trial; exposure is estimated 24-hour urine sodium (Tanaka equations) from repeated spot urines, per 1 g increase, not an assigned dose
    Dose studied
    not reported

    Average 24-hour urine sodium levels were not associated with conversion to clinically definite MS over the 5-year follow-up (hazard ratio [HR] = 0.91, 95% confidence interval [CI] = 0.67-1.24 per 1g increase in estimated daily sodium intake), nor were they associated with clinical or MRI outcomes (new active lesions after 6 months: HR = 1.05, 95% CI = 0.97-1.13; relative change in T2 lesion volume: -0.11, 95% CI = -0.25 to 0.04; change in EDSS: -0.01, 95% CI = -0.09 to 0.08; relapse rate: HR = 0.78, 95% CI = 0.56-1.07).”

    Quoted verbatim from Sodium intake and multiple sclerosis activity and progression in BENEFIT.cohortPermalink
  4. Body massMoved: lowersEffect, as reportedMD−2.48[−4.31 to −0.66]Evidence: Very limitedPaper: PMID 404505752025
    Who
    Patients hospitalized for acute decompensated heart failure; supplemental sodium plus furosemide versus furosemide alone (furosemide in both arms); oral and intravenous sodium trials pooled
    Dose studied
    not reported

    Supplemental sodium with furosemide significantly decreased serum creatinine (pooled net mean difference [NMD]: -0.33 mg/dL, 95% confidence interval [CI]: [-0.50 to -0.17]), brain natriuretic peptide (pooled NMD: -62.84 pg/mL, 95% CI: [-103.61 to -22.08]), and weight (pooled NMD: -2.48 kg, 95% CI: [-4.31 to -0.66]).”

    Quoted verbatim from Prescribed in-hospital sodium intake for decompensated heart failure: A systematic review and meta-analysis.meta-analysisPermalink
  5. Serum creatinine concentrationMoved: lowersEffect, as reportedMD−0.33[−0.5 to −0.17]Evidence: Very limitedPaper: PMID 404505752025
    Who
    Patients hospitalized for acute decompensated heart failure; supplemental sodium plus furosemide versus furosemide alone (furosemide in both arms); oral and intravenous sodium trials pooled
    Dose studied
    not reported

    Supplemental sodium with furosemide significantly decreased serum creatinine (pooled net mean difference [NMD]: -0.33 mg/dL, 95% confidence interval [CI]: [-0.50 to -0.17]), brain natriuretic peptide (pooled NMD: -62.84 pg/mL, 95% CI: [-103.61 to -22.08]), and weight (pooled NMD: -2.48 kg, 95% CI: [-4.31 to -0.66]).”

    Quoted verbatim from Prescribed in-hospital sodium intake for decompensated heart failure: A systematic review and meta-analysis.meta-analysisPermalink
  6. All-cause mortalityMoved: no difference foundEvidence: Very limitedreplicated ×1Paper: PMID 303459502019
    Who
    Adults in prospective cohort studies; dose-response of dietary sodium (Na) intake per 100 mg/day increment
    Dose studied
    100 mg/day increment in Na intake (observational gradient)

    No linear association (effect size; 95 % CI; I 2) was seen between 100mg/d increment in Na intake and CVD mortality (1·01; 0·97, 1·05; 98·4 %) or all-cause mortality (1·01; 1·00, 1·02; 89·2 %).”

    Quoted verbatim from Dose-response association of dietary sodium intake with all-cause and cardiovascular mortality: a systematic review and meta-analysis of prospective studies.meta-analysisPermalink
  7. Core body temperatureMoved: no difference foundEvidence: Very limitedPaper: PMID 379445072024
    Who
    Nine healthy participants (7 male, 2 female) during two 5-hour treadmill runs at 30°C
    Dose studied
    sodium chloride capsules replacing 100% of previously assessed sweat sodium losses, during a 5-hour run; placebo comparator

    No effect of sodium replacement was observed for heart rate, rectal temperature, thermal comfort, perceived exertion, or physiological strain index.”

    Quoted verbatim from Effect of Personalized Sodium Replacement on Fluid and Sodium Balance and Thermophysiological Strain During and After Ultraendurance Running in the Heat.crossoverPermalink
  8. Rating of perceived exertionMoved: no difference foundEvidence: Very limitedPaper: PMID 379445072024
    Who
    Nine healthy participants (7 male, 2 female) during two 5-hour treadmill runs at 30°C
    Dose studied
    sodium chloride capsules replacing 100% of previously assessed sweat sodium losses, during a 5-hour run; placebo comparator

    No effect of sodium replacement was observed for heart rate, rectal temperature, thermal comfort, perceived exertion, or physiological strain index.”

    Quoted verbatim from Effect of Personalized Sodium Replacement on Fluid and Sodium Balance and Thermophysiological Strain During and After Ultraendurance Running in the Heat.crossoverPermalink
  9. Serum sodium concentrationMoved: raisesEvidence: Very limitedPaper: PMID 379445072024
    Who
    Nine healthy participants (7 male, 2 female) during two 5-hour treadmill runs in the heat; change in plasma sodium at 2.5 hours and postexercise
    Dose studied
    sodium chloride capsules replacing 100% of previously assessed sweat sodium losses, during a 5-hour run; placebo comparator

    Plasma sodium concentration increased in both trials, but to a greater extent in SODIUM at 2.5 hours (mean [SD]: 4 [4] mmol·L-1 vs 1 [5] mmol·L-1; P < .05) and postexercise (4 [3] mmol·L-1 vs 1 [5] mmol·L-1; P < .05).”

    Quoted verbatim from Effect of Personalized Sodium Replacement on Fluid and Sodium Balance and Thermophysiological Strain During and After Ultraendurance Running in the Heat.crossoverPermalink

No dose is advised.

  • RR risk ratio · MD mean difference. Brackets: the interval as reported.
  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed
  • Industry funding: named on its row.

03 · identity

Structure

AtomNa⁺
fig. 4Sodium · atom and ion, one scale for every element
Atomic radius
180 pm
Ionic radius, Na⁺
102 pm
Electronegativity
0.93 Pauling
Charge
+1
SMILES
[Na+]

04 · reach

What it touches on the way

40 entities · assembled from reference reactions

  1. SLC38A2Protein2,556 paths · 136 endpointsinferred
  2. SLC1A3Protein349 paths · 51 endpointsinferred
  3. SLC1A2Protein334 paths · 42 endpointsinferred
  4. SLC1A5Protein325 paths · 20 endpointsinferred
  5. ATP1A1Protein297 paths · 149 endpointsinferred
  6. SLC6A6Protein193 paths · 25 endpointsinferred
  7. SLC6A1Protein170 paths · 43 endpointsinferred
  8. SLC10A6Protein165 paths · 11 endpointsinferred
  9. ATP1A2Protein139 paths · 73 endpointsinferred
  10. SLC27A3Protein128 paths · 16 endpointsinferred
  11. SLC6A8Protein108 paths · 54 endpointsinferred
  12. AQP1Protein98 paths · 97 endpointsinferred
Show the remaining 28Show the first 12Every entity, on one page

Where it reaches

28 regions · transporter routes

  1. Brainnervous50 routesinferred
  2. Male reproductivereproductive32 routesinferred
  3. Female reproductivereproductive31 routesinferred
  4. Blood vesselscardiovascular21 routesinferred
  5. Colon and rectumdigestive21 routesinferred
  6. Heartcardiovascular21 routesinferred
  7. Mouth and oesophagusdigestive21 routesinferred
  8. Nerve and spinal cordnervous21 routesinferred
  9. Blood and immuneimmune18 routesinferred
  10. Small intestinedigestive18 routesinferred
  11. Airway and sinusesrespiratory17 routesinferred
  12. Eyenervous17 routesinferred
Show the remaining 16Show the first 12
  1. Lungrespiratory15 routesinferred
  2. Pancreasendocrine15 routesinferred
  3. Thyroidendocrine15 routesinferred
  4. Skeletal musclemusculoskeletal14 routesinferred
  5. Skinintegumentary14 routesinferred
  6. Stomachdigestive14 routesinferred
  7. Adrenal glandendocrine12 routesinferred
  8. Bladderurinary12 routesinferred
  9. Kidneyurinary11 routesinferred
  10. Bone and jointmusculoskeletal9 routesinferred
  11. Breastreproductive9 routesinferred
  12. Gallbladderdigestive6 routesinferred
  13. Liverdigestive6 routesinferred
  14. Spleenimmune6 routesinferred
  15. Adipose tissueintegumentary5 routesinferred
  16. Peritoneumdigestive4 routesinferred

05 · documented · reference

Interactions

Documented interactions
None reported

Pairs that share biology

What the reference databases state

Reference statements
1,23001 ProteinACE2, ANO9, AQP1, AQP6, ASIC1, ASIC2, and 116 moreNamed from the first 300 of 1,230 statementsinferred, one hop from sodium
Reactions · Rhea
830reactions
1,230Reference statements

What the reference databases state

Evidence key

Statements

1,230 statements

sodium(1+) is transported by each · Sources: Human-GEM, Rhea

Show the next 110Show the first 12

300 of 1,230 statements listed here · all 1,230 through the API

830Reactions

06 · on the label · 15,564 products

Labelled products

Source: NIH DSLD · Ingredient: sodium(1+) · 15,564 products · Declared amount per serving (the first 1,000 shown): 0.1–3,120 mg · 2 amounts above the serving weight, left out

964 labels of the first 1,000 shown state an amount36 do not

  • 21st CenturyMaximum Strength Glucosamine & Chondroitin Plus115 mgper 1 tabletDSLD:11284
  • 21st CenturyMaximum Strength Glucosamine & Chondroitin Plus115 mgper 1 tabletDSLD:11286
  • 21st Century Zoo FriendsComplete5 mgper 1 tabletDSLD:11637
  • 360 NutritionApple Cider Vinegar Cleanse10 mgper 1 TbspDSLD:180144
  • 360 NutritionTurmeric Cleanse5 mgper 1 TbspDSLD:180156
  • Advanced Nutrition SystemsDAA Test-53,120 mgper 4 capsulesDSLD:180473
  • Advanced Nutrition SystemsDAA Test-53,120 mgper 4 capsulesDSLD:180479
  • Advanced Nutrition SystemsGalvanized + Ripped Lemon Lime IceSodium, as Sodium Chloride25 mgper 13.3 gDSLD:180566
  • Advanced Nutrition SystemsGalvanized + Ripped Patriot PopSodium, as Sodium Chloride25 mgper 13.7 gDSLD:180561
  • Advanced Nutrition SystemsGalvanized + Strength Blue Razz Sour Candy5 mgper 15.5 gDSLD:180488
  • Advanced Nutrition SystemsGalvanized + Strength Wild Fruit Tarts5 mgper 15.3 gDSLD:180535
  • Advanced Nutrition SystemsSurge 2.0 Fruit Punch5 mgper 22.1 gDSLD:180393
Show the remaining 15,552Show the first 12

Label record: NIH Office of Dietary Supplements · CC0

07 · the record

Sources

330

papers screened for sodium

admitted
7
read and discarded
307
not read yet
16

The screening record, every paper and why

Sources cited

6 papers · 9 findings

1 admitted at screening, no finding yet

Show every paper citedHide the papers cited

Other names · 6

Na(+) · Na+ · SODIUM ION

systematic · sodium cation

systematic · sodium(1+) ion

systematic · sodium(I) cation

971Endpoints measured, not recorded as findingsEvery row, on one page
102Papers indexed under sodium